Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.48 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.41 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7746480 | 0.88 | NPC1 (0.45) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL151590 | 0.87 | ALDH1A1 (0.59) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| Hydrochloric Acid SCHEMBL10746200 | 0.85 | ALDH1A1 (0.57) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL27753903 | 0.81 | NPC1 (0.46) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL10365909 | 0.79 | ALDH1A1 (0.52) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL504020 | 0.79 | LMNA (0.50) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL29693606 | 0.79 | LMNA (0.50) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL8198679 | 0.79 | PDE2A (0.52) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL11834614 | 0.79 | ALDH1A1 (0.46) | ALDH1A1NPC1RAB9ADYRK1AGRM4 | |
| SCHEMBL754480 | 0.79 | NUDT1 (0.61) | ALDH1A1NPC1RAB9AGRM4NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026097624-A1 | METHOD FOR PREPARING CHLORINE-RESISTANT NANOFILTRATION MEMBRANE, AND CHLORINE-RESISTANT NANOFILTRATION MEMBRANE PREPARED THEREWITH | 沃顿科技股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-122006472-A | Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method | 沃顿科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119285001-A | Organic wastewater treatment agent and preparation method thereof | 武汉市欣慕沛环保有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2026097624-A1 | METHOD FOR PREPARING CHLORINE-RESISTANT NANOFILTRATION MEMBRANE, AND CHLORINE-RESISTANT NANOFILTRATION MEMBRANE PREPARED THEREWITH | 沃顿科技股份有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-122006472-A | Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method | 沃顿科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119285001-B | Organic wastewater treatment agent and preparation method thereof | 岳朋 | 2025-07-01 | — | — | CN | disclosed |
| CN-119285001-A | Organic wastewater treatment agent and preparation method thereof | 武汉市欣慕沛环保有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119285001-A | Organic wastewater treatment agent and preparation method thereof | 武汉市欣慕沛环保有限公司 | 2025-01-10 | — | — | CN | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-112004845-B | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate, and semiconductor device | 三菱瓦斯化学株式会社 | 2022-05-31 | — | — | CN | disclosed |
| US-20210401992-A1 | METABOLICALLY STABLE PRODRUGS | TSRL, INC. (US) | 2021-12-30 | — | — | US | disclosed |
| US-20050038058-A1 | Novel compounds and methods for therapy | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY | 2005-02-17 | — | — | US | disclosed |
| US-6818633-B2 | Antiviral for RNA or DNA viruses such as HIV, HBV or HSV; acyclic pyrimidine nucleoside phosphonate analogues; 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidine; ; alkylating the 6-hydroxypyrimidine base with a dialkyl 2-chloroethoxymethylphosphonate | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 2004-11-16 | — | — | US | disclosed |
| EP-1406911-A1 | 6-[2-(PHOSPHONOMETHOXY)ALKOXY]PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 2004-04-14 | — | — | EP | disclosed |
| US-20030109499-A1 | Novel compounds and methods for therapy | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ACADEMY OF SCIENCES | 2003-06-12 | — | — | US | disclosed |
| WO-2003002580-A1 | 6-`2-(PHOSPHONOMETHOXY)ALKOXY PYRIMIDINE DERIVATIVES HAVING ANTIVIRAL ACTIVITY | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OFTHE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 2003-01-09 | — | — | WO | disclosed |
| US-4826528-A | PLANT GROWTH REGULATORS | CELAMERCK GMBH & CO. KG. (DE) | 1989-05-02 | — | — | US | disclosed |
| US-4729995-A | ANTIALLERGENS | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 1988-03-08 | — | — | US | disclosed |
| EP-0243817-A1 | Novel pyrimidine compounds | Toyo Boseki Kabushiki Kaisha (JP) | 1987-11-04 | — | — | EP | disclosed |
| EP-0165572-A2 | Herbicidal sulfonyl urea | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1985-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038058-A1 | Novel compounds and methods for therapy | ZC3HAV1, IFNAR1, EIF2AK2 | ALDH1A1 2417/4885NPC1 217/4885RAB9A 1823/4885 |
| US-20210401992-A1 | METABOLICALLY STABLE PRODRUGS | CES1, CES2, CYP2S1 | ALDH1A1 681/4885NPC1 358/4885RAB9A 3531/4885 |
| US-20030109499-A1 | Novel compounds and methods for therapy | IFNAR1, ZC3HAV1, EIF2AK2 | ALDH1A1 1605/4885NPC1 173/4885RAB9A 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.